The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
The Guam Memorial Hospital Authority said its acquisition of its first-ever intra-aortic balloon pump is a significant ...
Patients who have acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) experience elevated mortality rates ...
a physician in the Cardiac Intensive Care Unit at Niguarda Metropolitan Hospital in Milan and a co-principal investigator on the study. Cardiogenic shock is a life-threatening medical emergency ...
Cardiogenic shock remains a challenging clinical syndrome characterized by critically impaired cardiac output, systemic hypoperfusion, and high mortality ...